Abstract
Epilepsy is a neurological disease with variable etiology and clinical manifestation, affecting more than 50 million people worldwide. Although the ultimate precipitators of seizures are neurons, it is becoming evident that epileptic activity is associated with changes in the function of other cell types, including those consisting the blood-brain barrier (BBB) and regulating its permeability. The interrelationships between impaired BBB function and epilepsy are complex, as BBB dysfunction may both lead to seizures and be induced by epileptic activity. In this article, we review alterations in key BBB properties that have been found in patients with epilepsy and in animal models of the disease. We highlight emerging biomarkers for individualized treatment, implications for pharmacotherapy, and potential BBB-related targets for drug development.
| Original language | English |
|---|---|
| Pages (from-to) | 973-988 |
| Number of pages | 16 |
| Journal | AAPS Journal |
| Volume | 19 |
| Issue number | 4 |
| DOIs | |
| State | Published - 1 Jul 2017 |
Bibliographical note
Publisher Copyright:© 2017, American Association of Pharmaceutical Scientists.
Keywords
- antiepileptic drugs
- blood-brain barrier
- drug transporters
- epilepsy
- status epilepticus